Let’s dive deeper into #JITC article “Distinct host preconditioning regimens differentially impact antitumor potency of adoptively transferred Th17 cells” by Megen Wittling Paulos Lab Hannah Knochelmann, MD PhD Anna Cole Guillermo O. Rangel Rivera @MeganMWyatt from Winship Cancer Institute of Emory University Emory MSTP 1/11

Meet the Author: Megen Wittling (Megen Wittling), an MSTP student from Paulos Lab @emoryuniversity, is 1st author of “Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells,” recently published in #JITC! 1/7

Our new review is out in Cancers MDPI with Megen Wittling Anna Cole Brianna Brammer #KaileyDiatikar Schmitt Lab Paulos Lab Strategies for Improving CAR T Cell Persistence in Solid Tumors mdpi.com/2914846 #mdpicancers via Cancers MDPI

Congratulations to my little brother who successfully defended his thesis! linkedin.com/posts/ulises-r…

Getting back to biking my favorite route.

A complete team work. Thanks to National Cancer Institute and all of my trainees, as well as my amazing collaborators, here and outside of Pelotonia Institute for Immuno-Oncology!! The goal of this grant is to advance our anti-GARP Ab to the clinics.

Scenic view of Charleston

Training for ⁦LOWVELO⁩. First time ever trying to do 80 miles! Pray the rhabdo away!

Han Lab at the LOWVELO Trainee Symposium. MUSC Hollings Cancer Center Congratulations to Karreon, Alexis and Deanna for great presentations!

I forgot how stressful big experiments are. Definitely do not miss that about PhD.

I’ll be talking about how host preconditioning augments T cell therapy ⁦Society for Immunotherapy of Cancer⁩ #SITC2024 new work by ⁦Megen Wittling⁩ as in her review and in her new JITC paper. ⁦⁦Society for Immunotherapy of Cancer⁩ ⁦Emory MSTP⁩ check out her poster.

Always an inspiration to hear Dr Stephanie Goff present on #TILs. We need to stop thinking about this as palliative therapy! TILs have the potential to CURE- complete responders from National Cancer Institute with 10 year melanoma-specific survival of 96%. Unmodified TILs are just a starting

THE (IMMUNOLOGICALLY) INVISIBLE MOUSE IS HERE! Forget about universal blood donor, this could be a universal organ donor! But what does it mean to be born and grow up with an immune system that doesn’t know what self looks like? #immunologymatters cell.com/iscience/fullt…

Out this week Science Magazine by first release: Specific combinations of nutrients and metabolic enzymes determine T cell differentiation via loci-specific histone acetylations. buff.ly/4gvqKTz From Shixin Ma, Sue Kaech and colleagues #Immunology #immunometabolism

1. I feel like this is such obvious advice that it's taken for granted & so no one says this to young scientists but READ PAPERS, read all the papers. As you move up in your career you'll have a lot less time to do this. Read everything that appeals to you not just in your field

CD2 expression is co-regulated with stemness- and exhaustion-associated factors in human T cells doi.org/10.1101/2025.0…

Great work from excellent scientists! I remember talking about this exciting project with Megen Wittling while I was finishing my PhD training! Glad to see this come out!

The ⁦Paulos Lab⁩ is thrilled to work with the very talented Anna Baj ⁦Anna Baj⁩ for her third rotation in the ⁦Emory Cancer Biology Program⁩ 💥

Excited to present at AACR 2025!

Check out our new paper in Hepatology on how myeloid cells limit #immunotherapy in preclinical #cholangiocarcinoma models! Disease site matters! Collaborative effort with Chrystal Paulos and many others Winship Cancer Institute of Emory University Sidney Kimmel Comprehensive Cancer Center Vanderbilt University pubmed.ncbi.nlm.nih.gov/40590857/